Effects of Raloxifene and GnRH-a on VEGF expression in cultured human uterine leiomyoma cells
Author | Taravat Fakheri | en |
Author | Kamran Mansouri | en |
Author | Sahar Rashidi | en |
Author | Mansour Rezaei | en |
Author | Sara Daeichin | en |
Author | Anisodowleh Nankali | en |
Issued Date | 2014-05-30 | en |
Abstract | Background: uterine leiomyoma is the most common benign pelvic tumor in women of reproductive age and is frequently associated with abnormal uterine bleeding and pelvic pressure. Combined therapy of gonadotropin-releasing hormone analogue (GnRH-a) and selective estrogen receptor inhibitors (raloxifene) reduce the size of leiomyoma. | en |
DOI | https://doi.org/10.22110/jkums.v18i2.1552 | en |
Keyword | Leiomyoma | en |
Keyword | raloxifene | en |
Keyword | VEGF | en |
Keyword | GnRH-a | en |
Publisher | Brieflands | en |
Title | Effects of Raloxifene and GnRH-a on VEGF expression in cultured human uterine leiomyoma cells | en |
Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 74164.pdf
- Size:
- 229.01 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF